Not logged in Share Save
Share Save
Share Save
ctDNA-based molecular residual disease and survival in resectable colorectal cancer Nakamura, Yoshiaki; Watanabe, Jun; Akazawa, Naoya; Hirata, Keiji; Kataoka, Kozo; Yokota, Mitsuru; Kato, Kentaro; Kotaka, Masahito; Kagawa, Yoshinori; Yeh, Kun-Huei; Mishima, Saori; Yukami, Hiroki; Ando, Koji; Miyo, Masaaki; Misumi, Toshihiro; Yamazaki, Kentaro; Ebi, Hiromichi; Okita, Kenji; Hamabe, Atsushi; Sokuoka, Hiroki; Kobayashi, Satoshi; Laliotis, George; Aushev, Vasily N.; Sharma, Shruti; Jurdi, Adham; Liu, Minetta C.; Aleshin, Alexey; Rabinowitz, Matthew; Bando, Hideaki; Taniguchi, Hiroya; Takemasa, Ichiro; Kato, Takeshi; Kotani, Daisuke; Mori, Masaki; Yoshino, Takayuki; Oki, Eiji Share Save
Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancer Kitai, Hidenori; Choi, Philip H.; Yang, Yu C.; Boyer, Jacob A.; Whaley, Adele; Pancholi, Priya; Thant, Claire; Reiter, Jason; Chen, Kevin; Markov, Vladimir; Taniguchi, Hirokazu; Yamaguchi, Rui; Ebi, Hiromichi; Evans, James; Jiang, Jingjing; Lee, Bianca; Wildes, David; de Stanchina, Elisa; Smith, Jacqueline A. M.; Singh, Mallika; Rosen, Neal Share Save
Association between skin toxicity and ef fi cacy of necitumumab in squamous non-small-cell lung cancer: a pooled analysis of two randomized clinical trials-SQUIRE and JFCM Watanabe, S.; Yoshioka, H.; Sakai, H.; Hotta, K.; Takenoyama, M.; Yamada, K.; Sugawara, S.; Takiguchi, Y.; Hosomi, Y.; Tomii, K.; Niho, S.; Nishio, M.; Kato, T.; Takahashi, T.; Ebi, H.; Aono, M.; Yamamoto, N.; Ohe, Y.; Nakagawa, K. Share Save
Share Save
SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition Lai, Xianning; Lui, Sarah Kit Leng; Lam, Hiu Yan; Adachi, Yuta; Sim, Wen Jing; Vasilevski, Natali; Armstrong, Nicola J.; Bridgeman, Stephanie Claire; Main, Nathan Michael; Tan, Tuan Zea; Tirnitz-Parker, Janina E. E.; Thiery, Jean Paul; Ebi, Hiromichi; Kumar, Alan Prem; Eichhorn, Pieter Johan Adam Share Save
Prospective study of comprehensive genomic profiling for chemotherapy-naive cancer patients (FIRST-Dx study) Ebi, Hiromichi; Matsubara, Junichi; Mukai, Kumi; Kondo, Tomohiro; Yoshioka, Masahiro; Kage, Hidenori; Oda, Katsutoshi; Kudo, Ryo; Ikeda, Sadakatsu; Hayashi, Ryuji; Tokudome, Naomi; Yamamoto, Nobuyuki; Muro, Kei; Muto, Manabu Share Save
Share Save
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer Yoshino, T.; Cervantes, A.; Bando, H.; Martinelli, E.; Oki, E.; Xu, R. -H.; Mulansari, N. A.; Babu, K. Govind; Lee, M. A.; Tan, C. K.; Cornelio, G.; Chong, D. Q.; Chen, L. -T.; Tanasanvimon, S.; Prasongsook, N.; Yeh, K. -H.; Chua, C.; Sacdalan, M. D.; Sow (Jenson), W. J.; Kim, S. T.; Chacko, R. T.; Syaiful, R. A.; Zhang, S. Z.; Curigliano, G.; Mishima, S.; Nakamura, Y.; Ebi, H.; Sunakawa, Y.; Takahashi, M.; Baba, E.; Peters, S.; Ishioka, C.; Pentheroudakis, G. Share Save
ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1 Su, Wenjing; Mukherjee, Radha; Yaeger, Rona; Son, Jieun; Xu, Jianing; Na, Na; Timaul, Neilawattie Merna; Hechtman, Jaclyn; Paroder, Viktoriya; Lin, Mika; Mattar, Marissa; Qiu, Juan; Chang, Qing; Zhao, Huiyong; Zhang, Jonathan; Little, Megan; Adachi, Yuta; Han, Sae-Won; Taylor, Barry S.; Ebi, Hiromichi; Abdel-Wahab, Omar; de Stanchina, Elisa; Rudin, Charles M.; Janne, Pasi A.; McCormick, Frank; Yao, Zhan; Rosen, Neal Share Save
Impact of plasma VEGF-A, VEGF-D and PlGF on the efficacy of 2nd-line chemotherapy combined with biologics in mCRC Yamazaki, Kentaro; Yuki, Satoshi; Taniguchi, Hiroya; Bando, Hideaki; Sunakawa, Yu; Shiozawa, Manabu; Yasui, Hisateru; Takahashi, Naoki; Satake, Hironaga; Matsuhashi, Nobuhisa; Kanazawa, Akiyoshi; Horita, Yosuke; Goto, Masahiro; Okano, Naohiro; Yamashita, Kaname; Tsuji, Akihito; Ebi, Hiromichi; Abe, Yukiko; Nomura, Shogo; Yoshino, Takayuki Share Save
Prospective trial of comprehensive genomic profiling for patients with chemotherapy-naive cancer (FIRST-Dx trial) Matsubara, Junichi; Mukai, Kumi; Kage, Hidenori; Oda, Katsutoshi; Kudo, Ryo; Ikeda, Sadakatsu; Ebi, Hiromichi; Muro, Kei; Hayashi, Ryuji; Tokudome, Nahomi; Yamamoto, Nobuyuki; Muto, Manabu Share Save
High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition Cai, Jinyang; Jacob, Sheeba; Kurupi, Richard; Dalton, Krista M.; Coon, Colin; Greninger, Patricia; Egan, Regina K.; Stein, Giovanna T.; Murchie, Ellen; McClanaghan, Joseph; Adachi, Yuta; Hirade, Kentaro; Dozmorov, Mikhail; Glod, John; Boikos, Sosipatros A.; Ebi, Hiromichi; Hao, Huaixiang; Caponigro, Giordano; Benes, Cyril H.; Faber, Anthony C. Share Save
Share Save
Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial Nakamura, Yoshiaki; Okamoto, Wataru; Kato, Takeshi; Esaki, Taito; Kato, Ken; Komatsu, Yoshito; Yuki, Satoshi; Masuishi, Toshiki; Nishina, Tomohiro; Ebi, Hiromichi; Sawada, Kentaro; Taniguchi, Hiroya; Fuse, Nozomu; Nomura, Shogo; Fukui, Makoto; Matsuda, Seiko; Sakamoto, Yasutoshi; Uchigata, Hiroshi; Kitajima, Kana; Kuramoto, Naomi; Asakawa, Takashi; Olsen, Steve; Odegaard, Justin, I; Sato, Akihiro; Fujii, Satoshi; Ohtsu, Atsushi; Yoshino, Takayuki Share Save
Impact of plasma angiogenesis factors on the efficacy of 2nd-line chemotherapy combined with biologics in metastatic colorectal cancer (mCRC): Early efficacy results from GI-SCREEN CRC Ukit study Yuki, S.; Taniguchi, H.; Masuishi, T.; Shiozawa, M.; Bando, H.; Yamazaki, K.; Nishina, T.; Yasui, H.; Denda, T.; Sunakawa, Y.; Satake, H.; Yoshida, K.; Kanazawa, A.; Oki, E.; Okugawa, Y.; Ebi, H.; Abe, Y.; Nomura, S.; Asano, C.; Yoshino, T. Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Not logged in.png){kind=icon}